Phenoxy compounds
Medchemexpress LLC HY-14656 5g , Diltiazem (hydrochloride) CRD-401 CAS:33286-22-5 Purity:98%
Medchemexpress, HY-14656 5g Diltiazem (hydrochloride) CRD-401 CAS:33286-22-5 Formula:C22H27ClN2O4S Purity:98% Diltiazem hydrochloride is a Ca 2+ influx inhibitor (slow channel blocker or calcium antagonist). Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC KRAS G12C inhibitor 15 | 2349393-21-9 | 98.5% | 498.91 g/mol | C25H21ClF2N4O3 | 100MG
KRAS G12C inhibitor 15 is a research-grade small-molecule inhibitor selective for the KRAS G12C mutant, derived from patent WO2019110751A1 (compound 22). It is reported to inhibit KRAS G12C with an IC50 of 5 nM and is supplied as a solid for laboratory research use only.
- Potent KRAS G12C inhibition (IC50 5 nM).
- High purity (~98.5%).
- Molecular weight 498.91 g/mol; formula C25H21ClF2N4O3.
- White to yellow solid suitable for biochemical and cellular assays.
- Supplied as 100 MG for research use only.
- Derived from patent WO2019110751A1 (compound 22).
Medchemexpress LLC KRAS G12C inhibitor 15 | 2349393-21-9 | 98.5% | 498.91 | C25H21ClF2N4O3 | 10MG
KRAS G12C inhibitor 15 is a potent small-molecule inhibitor of the oncogenic KRAS G12C mutant, reported from patent WO2019110751A1 (compound 22). It is supplied as a high-purity solid and as a DMSO solution for research use, and biochemical assays report an IC50 of 5 nM for KRAS G12C.
- Potent KRAS G12C inhibition (IC50 = 5 nM).
- High purity, 98.5%.
- Molecular weight 498.91 and formula C25H21ClF2N4O3.
- Available in small solid quantities and as a 10 mM solution in DMSO.
- Suitable for biochemical and cell-based research applications.
Medchemexpress LLC Kras G12c inhibitor 15 | 2349393-21-9 | 98.5% | 498.91 | C25H21ClF2N4O3 | 25MG
KRAS G12C inhibitor 15 is a research-grade small-molecule inhibitor of the oncogenic KRAS G12C mutant. It was reported in patent WO2019110751A1 (compound 22) and shows potent biochemical activity; supplied as a solid for laboratory research only - consult the SDS and COA for handling and storage.
- Potent KRAS G12C inhibition (IC50 ≈ 5 nM).
- High purity (98.5%).
- Molecular formula C25H21ClF2N4O3.
- Molecular weight 498.91 g/mol.
- Appearance solid, white to yellow.
- Storage: protect from light and store under nitrogen; in solvent -80°C (6 months) or -20°C (1 month).
- Available as solid and as 10 mM solutions in DMSO; common pack sizes up to 100 mg.
Medchemexpress LLC KRAS G12C inhibitor 15 | 2349393-21-9 | 98.5% | 498.91 g/mol | C25H21ClF2N4O3 | 50MG
KRAS G12C inhibitor 15 is a small-molecule research compound reported to selectively inhibit the oncogenic KRAS G12C mutant. Described in patent WO2019110751A1 (compound 22), it demonstrates subnanomolar-nanomolar biochemical potency and is supplied as a high-purity solid for preclinical and biochemical studies.
- Potent KRAS G12C inhibitor with reported IC50 ≈ 5 nM.
- Registered CAS number 2349393-21-9 for unambiguous identification.
- High purity suitable for research applications (manufacturer listed ~98.5%).
- Molecular formula C25H21ClF2N4O3 and molecular weight 498.91 g/mol.
- Intended for biochemical assays, cellular studies, and tool-compound research.
- Supplied as a solid; store at -20 °C in a dry, inert atmosphere for stability.
- Available in multiple small pack sizes to support dose-range experiments.